Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains

Dermatology

Volumn 205, Issue 2-3, 2002, Pages 260-264

  Gloor, Max ^a   Wasik, Barbara ^b   Becker, Andrea ^b   Höffler, Ulrich ^b  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^b NONE

Author keywords

Antibiotic resistance; Clindamycin; Erythromycin; Lipase activity; Propionibacterium acnes

Indexed keywords

AGAR; ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; REAGENT; TRIACYLGLYCEROL LIPASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; INHIBITION KINETICS; LIPOLYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN ANALYSIS; PROTEIN SYNTHESIS;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; LIPASE; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES;

EID: 0036977426     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065856     Document Type: Article

References (35)

1. Toyoda M, Morohashi M: An overview of topical antibiotics for acne treatment. Dermatology 1998;196:130-134.
2. Norris JFB, Cunliffe WJ: A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988;118:651-659.
3. Zouboulis CC: Is acne vulgaris a genuine inflammatory disease? Dermatology 2001;203: 277-279.
4. Puhvel SM, Hoffman IK, Reisner RM, Sternberg TH: Dermal hypersensitivity of patients with acne vulgaris to Corynebacterium acnes. J Invest Dermatol 1967;49:154-158.
5. Jappe U, Ingham E, Henwood J, Holland KT: Propionibacterium acnes and inflammation in acne:P. acnes has T-cell mitogenic activity. Br J Dermatol 2002;146:202-209.
6. Webster G: Inflammation in acne vulgaris. J Am Acad Dermatol 1995;33:247-253.
7. Lee WL, Shalita AR, Suntharalingam K, Fikrid SM: Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun 1982;35:71-78.
8. Hassing G: Inhibition of Corynebacterium acnes lipase by tetracycline. J Invest Dermatol 1971;567:189-192.
9. Puhvel SM, Reisner RM: Effect of antibiotics on the lipases of Corynebacterium acnes in vitro. Arch Dermatol 1972;106:45-49.
10. Webster GF, McGinley KJ, Leyden JJ: Inhibition of lipase production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol 1981;104:453-457.
11. Unkles SE, Gemmell CG: Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. Antimicrob Agents Chemother 1982;21:39-43.
12. Akamatsu H, Nishijima S. Takahashi M, Ushijima T, Asada Y: Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5. J Dermatol 1991;18:247-251.
13. Leyden JJ: Antibiotic resistent acne. Cutis 1976;17:593-596.
14. Crawford WW, Crawford IP, Stoughton RB, Cornell RC: Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol 1979;72:187-190.
15. Eady EA, Jones CE, Vyakrnam S, Cove JH, Cunliffe WJ: Increasing prevalence of antibiotic resistant propionibacteria on the skin of acne patients: Results of a 5 year study. Br J Dermatol 1997;137(suppl 50):34.
16. Forssman Th, Gloor M, Gehring W: Antibiotikaresistenzen bei Akne vulgaris - Eine retrospektive Untersuchung an einem antibiotisch vorbehandelten und einem unbehandelten Kollektiv. Z Hautkr 1994;659:828-894.
17. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM: Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983;8:41-45.
18. Espersen F: Resistance to antibiotics used in dermatological practice. Br J Dermatol 1998; 139(suppl 53):4-8.
19. Nishijima S, Akamatsu H, Kurokawa I, Asada Y: The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. J Dermatol 1994;21:166-171.
20. Coates P, Adams CA, Cunliffe WJ, McGinley KT, Eady EA, Leyden JJ, Ravenscroft J, Vyakrnam S, Vowels B: Does oral isotretinoin prevent Propionibacterium acnes resistance? Dermatology 1997;195(suppl 1):4-9.
21. Eijkman C: Über Enzyme bei Bakterien und Schimmelpilzen. Zentralbl Bakt Parasitenkd Infektionskr 1901;29:841-848.
22. Jaeger KE, Ransac S, Dijkstra BW, Colson C, van Heuvel M, Misset O: Bacterial lipases. FEMS Microbiol Rev 1994;15:29-63.
23. Pablo G, Hamilton A, Bradley S, Fulton JE: Characteristics of the extracellular lipases from Corynebacterium acnes and Staphylococcus epidermidis. J Invest Dermatol 1974;63:231-238.
24. Hassing GS: Partial purification and some properties of a lipase from Corynebacterium acnes. Biochim Biophys Acta 1971;242:381-394.
25. Ingham E, Holland KT, Gowland G, Cunliffe WJ: Partial purification and characterization of lipase (EC 3.1.1.3) from Propionibacterium acnes. J Gen Microbiol 1981;124:393-401.
26. Miskin JE, Farrell AM, Cunliffe WJ: Propionibacterium acnes,a resident of lipid rich human skin, produces a 33 kDa extracellular lipase encoded by gehA. Microbiology 1997;143:1745-1755.
27. Weeks JG, McCarty L, Black T, Fulton JE: The inability of a bacterial lipase inhibitor to control acne vulgaris. J Invest Dermatol 1977;69:236-243.
28. Gribbon EM, Cunliffe WJ, Holland KT: Interaction of Propionibacterium acnes with skin lipids in vitro. J Gen Microbiol 1993;139:1745-1751.
29. Ross JI, Cove JH, Cunliffe WJ: Erythromycin and clindamycin resistance due to a mobile genetic element in cutaneous propionibacteria from acne patients: Poster demonstration on the 10th Congress of the European Academy of Dermatology and Venereology, Munich. J Eur Acad Dermatol Venereol 2001;15:132.
30. Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S: Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 2001;144:339-346.
31. Fluhr JW, Gloor M, Dietz P, Höffler U: In vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralbl Bakteriol 1999;289: 53-61.
32. Eady EA, Cove JH, Blake J, Holland KT, Cunliffe WJ: Recalcitrant acne vulgaris: Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988;118:415-423.
33. Eady EA, Cove JH, Holland KT, Cunliffe WJ: Erythromycin resistant propionibacteria in antibiotic treated acne patients: Association with therapeutic failure. Br J Dermatol 1989;121:51-57.
34. Guin JD, Reynolds R, Gielerak PL: Penetration of topical clindamycin into comedones. J Am Acad Dermatol 1980;3:153-156.
35. Gardner KJ, Cunliffe WJ, Eady EA, Cove JH: Variation in comedonal antibiotic concentrations following application of tetracycline for acne vulgaris. Br J Dermatol 1994;131:649-654.